CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease

Li XIONG; Jinghong ZHAO; Ting HE; Tangli XIAO; Chi LIU

doi:10.16016/j.2097-0927.202210008

您当前的位置：

首页 >

文章列表页 >

CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease

Basic Medicine | 更新时间：2026-01-09

- CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease
- Journal of Army Medical University Vol. 45, Issue 8, Pages: 810-816(2023)
- 作者机构：
  
  400037 重庆，陆军军医大学(第三军医大学)第二附属医院肾内科，全军肾脏病中心，重庆市慢性肾脏病防治重点实验室，重庆市肾病与泌尿系统疾病临床医学研究中心
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(82270762)
- DOI：10.16016/j.2097-0927.202210008
  CLC： R363.22;R587.2;R692
- Received：03 October 2022，
  
  Revised：2022-11-21，
  
  Published：30 April 2023
- 稿件说明：
移动端阅览
Li XIONG, Jinghong ZHAO, Ting HE, et al. CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease[J]. Journal of Army Medical University, 2023, 45(8): 810-816.
DOI：

Li XIONG, Jinghong ZHAO, Ting HE, et al. CPT1A protects against renal fibrosis in mouse model of diabetic kidney disease[J]. Journal of Army Medical University, 2023, 45(8): 810-816. DOI： 10.16016/j.2097-0927.202210008.

摘要

目的

探讨肉碱棕榈酰转移酶1A(palmitoyl-transferase 1A

CPT1A)在糖尿病肾病(diabetic kidney disease

DKD)肾间质纤维化中的作用。

方法

16只4周龄雄性C57BL/6小鼠随机分为(

=8)：对照组(Ctrl组，给予普通饲料喂养)和DKD组[通过高脂饮食联合链脲佐菌素(streptozotocin

STZ)制备DKD模型

]

。每4周收集小鼠24 h尿液，检测空腹血糖和体质量。建模16周(小鼠20周龄)后取材并检测2组小鼠血肌酐水平、尿蛋白/尿肌酐比值，PAS和Masson染色观察肾小球病理改变和肾间质纤维化程度，免疫组化染色、Western blot观察CPT1A及纤维化标志物的表达。体外培养人近端肾小管上皮细胞(proximal tubular cell line

HK-2)后分3组：正常对照(Ctrl)组、30 mmol/L高糖(high glucose

HG)组、30 mmol/L甘露醇(mannitol

M)组，孵育48 h后观察CPT1A、纤维化标志物的表达。CPT1A过表达质粒转染HK-2细胞后再予以30 mmol/L高糖处理，观察各组细胞形态和纤维化标志物的表达。

结果

与Ctrl组小鼠相比，DKD组小鼠肾小球体积增大、系膜基质增多和出现肾间质纤维化，同时血肌酐、尿蛋白/尿肌酐比值显著升高(

0.05)，肾组织CPT1A表达明显降低，而纤维化标志物表达显著升高。体外实验中：高糖导致HK-2细胞失去原有形态、呈长梭形改变，CPT1A表达降低和纤维化标志物表达升高，并与渗透压改变无关。而CPT1A过表达能抑制高糖诱导的HK-2细胞形态改变和纤维化标志物高表达。

结论

上调CPT1A表达可能对糖尿病肾病肾间质纤维化具有潜在的抑制作用。

Abstract

Objective

To determine the effect of carnitine palmitoyl-transferase 1A (CPT1A) on renal interstitial fibrosis in diabetic kidney disease (DKD).

Methods

A total of 16 4-week-old male C57BL/6 mice were randomly divided into Control (Ctrl) group (

=8) and DKD group (

=8). The mice of Ctrl group were fed with normal diet

and those from the DKD group were inflicted with intraperitoneal streptozotocin injection plus high fat diet (STZ/HFD) to induce DKD model. Their 24-hour urine were collected

and fasting blood glucose level and body weight were measured every 4 weeks. After 16 weeks of modeling

the mice (aged 20 weeks) were sacrificed

and the levels of serum creatinine

urine creatinine and urine albumin were measured. PAS and Masson stainings were used to analyze the renal glomerulus morphology and interstitial fibrosis. Immunohistochemical assay and Western blotting were performed to detect the expression of CPT1A and fibrosis markers. In

in vitro

study

human proximal tubular epithelial HK-2 cells were divided into Ctrl group

HG group (30 mmol/L glucose treatment)

and M group (30 mmol/L mannitol treatment). After treatment for 48 h

the protein levels of CPT1A and fibrosis markers were detected with Western blotting. After HK-2 cells were transfected with CPT1A overexpression plasmid and then treated with 30 mmol/L glucose

cell morphological changes and the expression of CPT1A and fibrosis markers were observed.

Results

The mice of the DKD group had obvious glomerulus hypertrophy

mesangial expansion and renal interstitial fibrosis

increased levels of serum creatinine and urine albumin/creatinine ratio (

0.05)

decreased CPT1A expression

and elevated protein levels of fibrosis markers when compared with the mice of the Ctrl group. In

in vitro

experiment

HG treatment induced the morphological changes of HK-2 cells into long spindle-shape

decreased level of CPT1A

and increased levels of fibrosis markers

which were not affected by alterations of osmotic pressure. However

CPT1A overexpression significantly reversed these HG-induce

d morphological changes and high expression of fibrosis markers.

Conclusion

Overexpression of CPT1A may show potential inhibitory effect on renal interstitial fibrosis in DKD mice.

关键词

Keywords

references

REUTENS A T. Epidemiology of diabetic kidney disease[J]. Med Clin North Am, 2013, 97(1): 1-18. DOI: 10.1016/j.mcna.2012.10.001.

SAMSU N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment[J]. Biomed Res Int, 2021, 2021: 1497449. DOI: 10.1155/2021/1497449.

ROBLES N R, VILLA J, GALLEGO R H. Non-proteinuric diabetic nephropathy[J]. J Clin Med, 2015, 4(9): 1761-1773. DOI: 10.3390/jcm4091761.

SCHLAEPFERI R, JOSHI M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential[J]. Endocrinology, 2020, 161(2): bqz046. DOI: 10.1210/endocr/bqz046.

GU L L, SUROLIA R, LARSON-CASEY J L, et al. Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling[J ] . Cell Death Differ, 2022, 29(1): 118-132. DOI: 10.1038/s41418-021-00840-w.

MIGUEL V, TITUAÑA J, HERRERO J I, et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis[J ] . J Clin Invest, 2021, 131(5): e140695. DOI: 10.1172/JCI140695.

FALKEVALL A, MEHLEM A, PALOMBO I, et al . Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease[J ] . Cell Metab, 2017, 25(3): 713-726. DOI: 10.1016/j.cmet.2017.01.004.

DOS SANTOS J M, TEWARI S, MENDES R H. The role of oxidative stress in the development of diabetes mellitus and its complications[J]. J Diabetes Res, 2019, 2019: 4189813. DOI: 10.1155/2019/4189813.

CHE D, ZHOU T, LAN Y Q, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells[J ] . Int J Mol Med, 2016, 38(6): 1815-1822. DOI: 10.3892/ijmm.2016.2768.

CONSOLE L, SCALISE M, GIANGREGORIO N, et al. The link between the mitochondrial fatty acid oxidation derangement and kidney injury[J ] . Front Physiol, 2020, 11: 794. DOI: 10.3389/fphys.2020.00794.

SONG X R, DU Z S, YAO Z Q, et al. Rhein improves renal fibrosis by restoring Cpt1a-mediated fatty acid oxidation through SirT1/STAT3/twist1 pathway[J ] . Molecules, 2022, 27(7): 2344. DOI: 10.3390/molecules27072344.

LAI C Q, PARNELL L D, SMITH C E, et al. Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A[J ] . Am J Clin Nutr, 2020, 112(5): 1200-1211. DOI: 10.1093/ajcn/nqaa233.

DÍAZ-RÚA R, PALOU A, OLIVER P. Cpt1a gene expression in peripheral blood mononuclear cells as an early biomarker of diet-related metabolic alterations[J]. Food Nutr Res, 2016, 60(1): 33554. DOI: 10.3402/fnr.v60.33554.

CHUNG K W, LEE E K, LEE M K, et al. Impairment of PPARα and the fatty acid oxidation pathway aggravates renal fibrosis during aging[J ] . J Am Soc Nephrol, 2018, 29(4): 1223-1237. DOI: 10.1681/asn.2017070802.

XIE Y H, XIAO Y, HUANG Q, et al. Role of the CTRP6/AMPK pathway in kidney fibrosis through the promotion of fatty acid oxidation[J ] . Eur J Pharmacol, 2021, 892: 173755. DOI:10.1016/j.ejphar.2020.173755.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of rhein lysinate on expression of COL1A1, COL3A1 and COL4A1 in renal tissues of SAMP 10 mice

Relationship between NALP3 expression and renal tubulointerstitial inflammation in diabetic kidney disease

Fosinopril down-regulates transforming growth factor-activated kinase 1 in rats with renal tubulointerstitial fibrosis

Related Author

林雅军

王梅梅

李冉

魏静波

章广玲

胡刚

甄永占

李开龙

Related Institution

No data

⁰